How radiation affects cervical cancer biology and treatment side effects
Official title: Understanding the Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
Run by University of California, San Diego · NCT07121543 · Data updated 2026-11-12
We will see if radiation therapy changes tissue factor and other molecular markers in women receiving radiation for cervical cancer by collecting blood and tumor samples before, during, and at the end of treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 20 (estimated) |
| Sponsor | University of California, San Diego Academic / other |
| Drugs / interventions | radiation, chemotherapy, immunotherapy |
| Locations | 1 site (La Jolla, California) |
| Status | Recruiting |
| Started | August 4, 2025 |
| Main results expected | August 2027 |
| Study ends | August 2027 |
| Registry record updated | August 13, 2025 |
| Trial ID | NCT07121543 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a pathological diagnosis of cervical cancer who are scheduled to receive brachytherapy and can provide blood and tissue samples are ideal candidates.
✕Probably not a fit
Patients seeking direct therapeutic benefit should note this is an observational sample‑collection study and those who are pregnant, lactating, or unable to provide tissue are not eligible and would not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects blood and tumor or vaginal biopsies from women with cervical cancer who are scheduled to receive brachytherapy as part of their standard chemo‑radiation care. Samples are taken before treatment, during therapy, and on the last day of radiation to measure tissue factor and other molecular changes over time. The investigators will use these specimens for translational laboratory analyses to identify pathways altered by radiation. Findings could point to molecular targets for future targeted radiotherapy or immunotherapy approaches.
Why it matters
Potential benefit: If successful, the study could reveal biological changes caused by radiation that lead to new targeted treatments or strategies to reduce side effects for women with cervical cancer.
How similar studies have gone: Prior translational studies have shown that radiotherapy can change tumor immune and molecular markers, though focusing on tissue factor in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older * Pathological diagnosis of cervical cancer * Scheduled to receive brachytherapy for cervical cancer Exclusion Criteria: * Pregnancy or lactation * Inability to provide a tissue sample
Where it's running
-
University of California San Diego
La Jolla, California, United States Recruiting
Study contacts
- Principal investigator: Jyoti Mayadev, MD — University of California, San Diego
- Study coordinator: Jyoti Mayadev, MD
- Email: CancerCTO@health.ucsd.edu
- Phone: 858-822-5354
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cervical screening and care options for women living with HIV who test positive for high-risk HPV
This study tests different ways to screen and manage high-risk HPV in women with HIV to see what might work best for them.
-
Hydrogel spacer to protect the rectum during cervical cancer radiotherapy
This study tests whether placing an absorbable hydrogel spacer between the cervix/vagina and rectum before definitive radiotherapy can reduce rectal radiation exposure for women with cervical cancer.
-
How cinema sessions during chemotherapy might help cervical cancer patients
We’re testing if watching films during chemotherapy helps cervical cancer patients feel less anxious and improve quality of life.
-
One-Finger Technique to identify the left upper ureter during para-aortic lymphadenectomy
This study tests a new surgical method to help surgeons find the left upper ureter during open para-aortic lymphadenectomy in women with gynecologic cancers.
-
Radiotherapy for gynecologic cancer with up to 10 metastatic sites
This registry follows adults with gynecologic cancer who have 1 to 10 active metastatic lesions and are treated with radiotherapy as part of routine care to see how such treatments work in real-world settings.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.